Kimberly A. Bolin is a senior patent agent in the Palo Alto Office and received her bachelor’s degree with honors in Chemistry from Wellesley College in 1990 and her D. Phil. from the University of Oxford, England in 1994. While an undergraduate Dr. Bolin was awarded National Science Foundation and Wellesley College grants for undergraduate research, including work with transition metal catalysts, retro-dative bonding in organosilanes and organic synthesis. Her graduate research in the laboratory of Professor Christopher Dobson, F.R.S. focused on the earliest events in protein folding, using nuclear magnetic resonance, circular dichroism spectroscopy and hydrogen exchange to model peptide analogues of potential folding initiation sites in hen egg white lysozyme and guinea pig -lactalbumin. While at Oxford Dr. Bolin was awarded an Overseas Research Student Award and was the recipient of the Oxford Centre for Molecular Science Industrial Affiliates Studentship. Dr. Bolin followed her graduate studies with a postdoctoral research fellowship at the University of California, Santa Cruz in the laboratory of Professor Glenn Millhauser. The recipient of a Petroleum Research Foundation grant awarded by the American Chemical Society, Dr. Bolin’s postdoctoral research focused on using spectroscopy, NMR, CD, ESR, and computer models to study transitions between so-called random coil and helical conformations in peptides. Her most recent work includes the determination of the NMR solution structure of the active C-terminal region of the human agouti related protein, a small, highly disulfide bridged protein implicated in weight homeostasis, and a review of and 310-helices in proteins and peptides. Dr. Bolin is the author of numerous scientific publications, an elected member of Sigma Xi, the scientific research honor society, and co-founder of the Monterey Bay Chapter of the Association for Women in Science (AWIS). Dr. Bolin is registered to practice before the U.S. Patent and Trademark Office.

Dr. Bolin is registered to practice before the U.S. Patent and Trademark Office and since joining Morrison & Foerster in 1999 has pursued patent prosecution in a range of technology fields including chemistry and biotechnology (e.g., small molecule pharmaceuticals, nanotechnology, drug delivery and antibodies) as well as providing patent support in a recent US/European patent enforcement arbitration setting.